These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 2891845)
1. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies. Wachtel SR; White FJ J Pharmacol Exp Ther; 1988 Jan; 244(1):410-6. PubMed ID: 2891845 [TBL] [Abstract][Full Text] [Related]
2. CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity. Meltzer LT; Christoffersen CL; Heffner TG; Freeman AS; Chiodo LA J Pharmacol Exp Ther; 1989 Oct; 251(1):123-30. PubMed ID: 2571714 [TBL] [Abstract][Full Text] [Related]
3. Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function. Matthews RT; McMillen BA; Sallis R; Blair D J Pharmacol Exp Ther; 1986 Oct; 239(1):124-31. PubMed ID: 2876091 [TBL] [Abstract][Full Text] [Related]
4. Effects of tiaspirone (BMY-13859) and a chemical congener (BMY-13980) on A9 and A10 dopamine neurons in the rat. White FJ; Wang RY Neuropharmacology; 1986 Sep; 25(9):995-1001. PubMed ID: 2877417 [TBL] [Abstract][Full Text] [Related]
5. Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment. Skarsfeldt T Synapse; 1992 Jan; 10(1):25-33. PubMed ID: 1346943 [TBL] [Abstract][Full Text] [Related]
6. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study. Minabe Y; Schechter L; Hashimoto K; Shirayama Y; Ashby CR Synapse; 2003 Dec; 50(3):181-90. PubMed ID: 14515335 [TBL] [Abstract][Full Text] [Related]
7. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats. Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395 [TBL] [Abstract][Full Text] [Related]
8. Effects of ICI 169,369, a selective serotonin2 antagonist, in electrophysiological tests predictive of antipsychotic activity. Goldstein JM; Litwin LC; Sutton EB; Malick JB J Pharmacol Exp Ther; 1989 Jun; 249(3):673-80. PubMed ID: 2567348 [TBL] [Abstract][Full Text] [Related]
9. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study. Nakamura K; Suzuki K; McCreary AC; Ashby CR Synapse; 2006 May; 59(6):359-67. PubMed ID: 16463399 [TBL] [Abstract][Full Text] [Related]
10. Diet and chronic haloperidol effects on rat midbrain dopamine neurons. Hamilton ME; Freeman AS Synapse; 2004 Jul; 53(1):1-5. PubMed ID: 15150734 [TBL] [Abstract][Full Text] [Related]
11. Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study. Ashby CR; Minabe Y; Stemp G; Hagan JJ; Middlemiss DN J Pharmacol Exp Ther; 2000 Sep; 294(3):1166-74. PubMed ID: 10945873 [TBL] [Abstract][Full Text] [Related]
12. CI-943, a potential antipsychotic agent. II. Neurochemical effects. Pugsley TA; Coughenour LL; Myers SL; Shih YH; Courtland GG; Berghoff W; Stewart SF J Pharmacol Exp Ther; 1989 Oct; 251(1):113-22. PubMed ID: 2571713 [TBL] [Abstract][Full Text] [Related]
13. Effect of the acute and chronic administration of the putative atypical antipsychotic drug Y-931 (8-fluoro-12- (4-methylpiperazin-1-yl)-6H-[1]benzothieno[2,3b][1,5] benzodiazepine maleate) on spontaneously active rat midbrain dopamine neurons: an in vivo electrophysiological study. Minabe Y; Hashimoto K; Shirayama Y; Ashby CR Synapse; 2004 Jan; 51(1):19-26. PubMed ID: 14579422 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the action of the stereoisomers of the psychostimulant 4-methylaminorex (4-MAX) on midbrain dopamine cells in the rat: an extracellular single unit study. Ashby CR; Pan H; Minabe Y; Toor A; Fishkin L; Wang RY Synapse; 1995 Aug; 20(4):351-61. PubMed ID: 7482294 [TBL] [Abstract][Full Text] [Related]
15. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens. Compton DR; Johnson KM J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468 [TBL] [Abstract][Full Text] [Related]
16. The acute and chronic administration of the 5-HT(2B/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell study. Blackburn TP; Suzuki K; Ashby CR Synapse; 2006 Jun; 59(8):502-12. PubMed ID: 16565966 [TBL] [Abstract][Full Text] [Related]
17. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors. Jeziorski M; White FJ Synapse; 1989; 4(4):267-80. PubMed ID: 2603146 [TBL] [Abstract][Full Text] [Related]
18. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. Chiodo LA; Bunney BS J Neurosci; 1983 Aug; 3(8):1607-19. PubMed ID: 6135762 [TBL] [Abstract][Full Text] [Related]
19. Further characterization of the effects of BMY 14802 on dopamine neuronal activity. Zhang J; Chiodo LA; Freeman AS Synapse; 1993 Dec; 15(4):276-84. PubMed ID: 7908761 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons. Hand TH; Hu XT; Wang RY Brain Res; 1987 Jul; 415(2):257-69. PubMed ID: 3607497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]